Evidence map›Paper›PMID 42736407›Full record

ArticleFacts, views & vision in ObGyn2026

Beyond hysteroscopic metroplasty: time to distinguish fundal from ampliative procedures.

Ursula Catena, Attilio Di Spiezio Sardo, Grigoris Grimbizis

Abstract read
In one paragraph

Article in Facts, views & vision in ObGyn, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ursula CatenaDepartment of Women's and Children's Health and Public Health, Agostino Gemelli University Hospital IRCCS, Rome, Italy.ORCID 0000-0002-7813-7993
Attilio Di Spiezio SardoDepartment of Public Health, University of Naples Federico II Faculty of Medicine, Naples, Italy.ORCID 0000-0001-6485-5735
Grigoris GrimbizisFirst Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID 0000-0002-6230-4638

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional intrauterine surgery has recently been proposed as a conceptual framework shifting the focus from anatomical correction alone toward restoration of uterine function and reproductive competence. However, hysteroscopic treatment of congenital uterine anomalies continues to be described under the umbrella term metroplasty, despite substantial differences in uterine morphology, surgical targets, and reconstructive objectives. In this Opinion Paper, we propose distinguishing two categories of hysteroscopic reconstructive procedures: fundal metroplasty and ampliative metroplasty. Fundal metroplasty primarily addresses midline fundal anomalies, most commonly the septate uterus, through a subtractive approach aimed at restoring normal uterine architecture. Conversely, ampliative metroplasty addresses globally restricted or dysmorphic uterine cavities through an expansive approach aimed at enlarging and reshaping the cavity. The use of a single term for these distinct procedures may contribute to conceptual ambiguity in surgical terminology. Rather than proposing a new classification system, we suggest terminology based on the anatomical target and reconstructive objective of hysteroscopic surgery. Distinguishing fundal from ampliative metroplasty may facilitate more precise communication and research and provide a clearer framework for hysteroscopic reconstructive surgery within the broader concept of Functional Intrauterine Surgery.

Indexed as

ampliative metroplastydysmorphic uterusFunctional intrauterine surgeryfundal metroplastyhysteroscopic metroplastyseptate uterus

Identifiers

PMID42736407
PMCPMC13575359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.